大麻使用者肝移植候选性和结果的回顾:是时候改变政策了吗?

Man Ting Kristina Yau, Trana Hussaini, Eric M Yoshida
{"title":"大麻使用者肝移植候选性和结果的回顾:是时候改变政策了吗?","authors":"Man Ting Kristina Yau,&nbsp;Trana Hussaini,&nbsp;Eric M Yoshida","doi":"10.3138/canlivj-2022-0038","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Recreational cannabis was legalized in Canada in 2018. A controversial contraindication for liver transplantation is cannabis. There is currently no consensus regarding cannabis use in liver transplant candidates. We aim to investigate liver transplantation candidacy and outcomes among cannabis users.</p><p><strong>Methods: </strong>English peer-reviewed studies on PubMed and Google Scholar were searched on September 9, 2022, using keywords including \"cannabis,\" \"liver transplantation,\" and their synonyms. Titles and abstracts were screened, followed by full texts. Reference lists were reviewed. Studies that investigated liver transplantation candidacy and outcomes among cannabis users were included.</p><p><strong>Results: </strong>The proportion of patients listed for liver transplantation was significantly less among cannabis users than among non-users. Time to listing was longer for cannabis users than non-users. The incidence of delisting was similar. There is an inconsistency between transplant centres regarding transplantation candidacy for cannabis users. While only 14% of Canadian centres had a policy in place and preferred candidates to abstain or decrease cannabis use before transplantation, a third of Canadian centres rejected cannabis users. Observational studies failed to demonstrate significant differences in patient survival between pre-transplantation cannabis users and non-users. However, self-reported mental health ratings were worse in post-transplantation cannabis users than in non-users and former users.</p><p><strong>Conclusions: </strong>Current observational data do not support a link between cannabis use and poor patient survival post-transplantation. However, high-quality prospective studies are needed to better elucidate the impact of cannabis use on liver transplantation outcomes. Liver transplant candidacy should be evaluated through a multidisciplinary and comprehensive approach considering all relevant psychosocial factors.</p>","PeriodicalId":9527,"journal":{"name":"Canadian liver journal","volume":"6 2","pages":"269-277"},"PeriodicalIF":0.0000,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10370722/pdf/canlivj-2022-0038.pdf","citationCount":"0","resultStr":"{\"title\":\"Review of liver transplantation candidacy and outcomes among patients who use cannabis: Is it time for a change in policy?\",\"authors\":\"Man Ting Kristina Yau,&nbsp;Trana Hussaini,&nbsp;Eric M Yoshida\",\"doi\":\"10.3138/canlivj-2022-0038\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Recreational cannabis was legalized in Canada in 2018. A controversial contraindication for liver transplantation is cannabis. There is currently no consensus regarding cannabis use in liver transplant candidates. We aim to investigate liver transplantation candidacy and outcomes among cannabis users.</p><p><strong>Methods: </strong>English peer-reviewed studies on PubMed and Google Scholar were searched on September 9, 2022, using keywords including \\\"cannabis,\\\" \\\"liver transplantation,\\\" and their synonyms. Titles and abstracts were screened, followed by full texts. Reference lists were reviewed. Studies that investigated liver transplantation candidacy and outcomes among cannabis users were included.</p><p><strong>Results: </strong>The proportion of patients listed for liver transplantation was significantly less among cannabis users than among non-users. Time to listing was longer for cannabis users than non-users. The incidence of delisting was similar. There is an inconsistency between transplant centres regarding transplantation candidacy for cannabis users. While only 14% of Canadian centres had a policy in place and preferred candidates to abstain or decrease cannabis use before transplantation, a third of Canadian centres rejected cannabis users. Observational studies failed to demonstrate significant differences in patient survival between pre-transplantation cannabis users and non-users. However, self-reported mental health ratings were worse in post-transplantation cannabis users than in non-users and former users.</p><p><strong>Conclusions: </strong>Current observational data do not support a link between cannabis use and poor patient survival post-transplantation. However, high-quality prospective studies are needed to better elucidate the impact of cannabis use on liver transplantation outcomes. Liver transplant candidacy should be evaluated through a multidisciplinary and comprehensive approach considering all relevant psychosocial factors.</p>\",\"PeriodicalId\":9527,\"journal\":{\"name\":\"Canadian liver journal\",\"volume\":\"6 2\",\"pages\":\"269-277\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10370722/pdf/canlivj-2022-0038.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Canadian liver journal\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.3138/canlivj-2022-0038\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Canadian liver journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3138/canlivj-2022-0038","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

背景:2018年,加拿大将娱乐性大麻合法化。肝移植的一个有争议的禁忌症是大麻。目前对肝移植候选人使用大麻尚无共识。我们的目的是调查大麻使用者的肝移植候选性和结果。方法:于2022年9月9日检索PubMed和Google Scholar上的英文同行评议研究,关键词包括“大麻”、“肝移植”及其同义词。先筛选标题和摘要,然后是全文。审查了参考文献清单。包括调查大麻使用者肝移植候选性和结果的研究。结果:大麻使用者中肝移植患者的比例明显低于非大麻使用者。大麻使用者的上市时间比非使用者要长。退市的发生率相似。移植中心之间关于大麻使用者的移植候选性存在不一致。虽然只有14%的加拿大中心制定了政策,并倾向于候选人在移植前放弃或减少使用大麻,但三分之一的加拿大中心拒绝大麻使用者。观察性研究未能证明移植前大麻使用者和非使用者在患者生存方面存在显著差异。然而,移植后大麻使用者自我报告的心理健康评级比非使用者和前使用者更差。结论:目前的观察数据不支持大麻使用与移植后患者生存差之间的联系。然而,需要高质量的前瞻性研究来更好地阐明大麻使用对肝移植结果的影响。考虑到所有相关的社会心理因素,应该通过多学科和综合的方法来评估肝移植的候选性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Review of liver transplantation candidacy and outcomes among patients who use cannabis: Is it time for a change in policy?

Background: Recreational cannabis was legalized in Canada in 2018. A controversial contraindication for liver transplantation is cannabis. There is currently no consensus regarding cannabis use in liver transplant candidates. We aim to investigate liver transplantation candidacy and outcomes among cannabis users.

Methods: English peer-reviewed studies on PubMed and Google Scholar were searched on September 9, 2022, using keywords including "cannabis," "liver transplantation," and their synonyms. Titles and abstracts were screened, followed by full texts. Reference lists were reviewed. Studies that investigated liver transplantation candidacy and outcomes among cannabis users were included.

Results: The proportion of patients listed for liver transplantation was significantly less among cannabis users than among non-users. Time to listing was longer for cannabis users than non-users. The incidence of delisting was similar. There is an inconsistency between transplant centres regarding transplantation candidacy for cannabis users. While only 14% of Canadian centres had a policy in place and preferred candidates to abstain or decrease cannabis use before transplantation, a third of Canadian centres rejected cannabis users. Observational studies failed to demonstrate significant differences in patient survival between pre-transplantation cannabis users and non-users. However, self-reported mental health ratings were worse in post-transplantation cannabis users than in non-users and former users.

Conclusions: Current observational data do not support a link between cannabis use and poor patient survival post-transplantation. However, high-quality prospective studies are needed to better elucidate the impact of cannabis use on liver transplantation outcomes. Liver transplant candidacy should be evaluated through a multidisciplinary and comprehensive approach considering all relevant psychosocial factors.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信